The Subclinical Deficiency Problem The published incidence figures usually define deficiency as a serum B12 result falling below a defined cutoff
Vajdi M, Khorvash F, Rouhani MH, Ghavami A, Clark CCT, Askari G
On average, patients on GLP-1 medication can lose 15% of their body weight in a year.* It is important to remember that results and timelines can vary
GLP-1 receptor agonist market size was valued at USD 52.92 billion in 2025 and is projected to reach USD 278.13 billion by 2033, exhibiting a CAGR of 23.41% during the forecast period
Oxidative stress in allergic and irritant dermatitis: from basic research to clinical management
If you experience intolerable side effects on one formulation or dose schedule, discussing alternative agents, slower titration, or a different administration route with your provider is a standard clinical approachnot a failure of the medication itself